You just read:

Regen BioPharma, Inc. Researchers Capitalize on Key Structure in Compounds that Activate Checkpoint NR2F6 for the Potential Treatment of Autoimmune Diseases

News provided by

Regen BioPharma Inc.

Oct 16, 2017, 08:00 ET